NeuroQure

02/25/2026

For parents, early answers can mean everything. ASD Insight™ offers a path to earlier intervention during this important developmental window.

We’re here to support families with finding science-backed answers to make informed decisions about their child’s path.

02/17/2026

Early detection of autism spectrum disorder (ASD) can significantly improve outcomes for children. The earlier you act, the more impact you can make, especially during critical early developmental windows.

https://www.neuroqure.com/patients?utm_source=facebook&utm_campaign=evergreen&utm_medium=social

02/12/2026

When it comes to your child’s development, waiting can be one of the hardest parts.

In this Modern Mommy Doc podcast episode, we talk about why earlier insight into autism risk matters, how it can reduce uncertainty for families, and how early awareness may help guide next steps during important developmental windows.

https://modernmommydoc.com/clarity-matters-how-early-autism-detection-can-change-a-child-s-lifelong-trajectory

02/09/2026

Launching ASD Insight™ is just the beginning.

Our vision is to transform neurodevelopmental care, bringing rigorous science, compassionate support, and innovative tools to families everywhere.

We’re grateful to the scientists, clinicians, families, and partners who’ve helped bring this test to life.

neuroqure.com?utm_source=facebook&utm_campaign=launch_organic&utm_medium=social

02/06/2026

Read Fierce Biotech’s take on how ASD Insight™ brings biology-based autism risk detection into the earliest stages of care:

NeuroQure, a startup diagnostics medtech that formed in 2023, has launched a

02/05/2026

Our founding scientist, John Jay Gargus MD, PhD, discusses the science behind ASD Insight™ with Healio:

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a skin punch biopsy that can be used as early as the second day after birth to detect the condition.Healio spoke to John “Jay” Gargus, MD, PhD, founding scientist and....

01/20/2026

It’s here! Earlier insights. Earlier action.

Introducing ASD Insight™: the first biology-based test that can detect autism risk at birth.

neuroqure.com?utm_source=facebook&utm_campaign=launch_organic&utm_medium=social

A new chapter starts today. 💙

12/31/2025

Big things are coming in 2026: earlier insights, earlier intervention, and brighter futures.

Here’s to a year of hope and progress! ✨

12/29/2025

For many families, earlier answers bring clarity, hope, and a plan.

When families understand risk for developmental delay earlier, they can access interventions that support learning, communication, and growth during the most important developmental window.

This is why NeuroQure exists.

12/24/2025

The holidays look different for every family.

To parents, families, and loved ones impacted by autism: we’re wishing you warmth and understanding. Your journey is deeply personal, and you are not alone.

Wishing you peace, joy, and connection this holiday season. 💙

12/22/2025

Earlier insights change lives.

We’re bringing scientifically backed, biology-based insights to families and clinicians with ASD Insight™, the first test capable of detecting autism risk at birth.

09/18/2025

We built NeuroQure because the current system waits for children to fall behind before it acts.

We believe science should meet families where they are: early, clearly, and compassionately.

This is healthcare, evolved.

www.neuroqure.com